Investors

At the forefront of mental wellness.

CNSX: MEND | OTC: MNNDF | FRA: 8TV

blue sky tree
blue sky tree

Nurosene is committed to finding solutions that will advance science, improve patient outcomes, and empower people suffering from poor mental health around the globe.

Dedicated to supporting you to live a healthier today and brighter tomorrow.

Subscribe for investor news

The Problem

78%

Nearly 8 in 10 adults (78%) say the coronavirus pandemic is a significant source of stress in their life.

264M

People are affected by depression globally. More women are affected than men and depression is one of the main causes of disability worldwide.

75-85%

People with mental disorders receive no treatment because of stigma, cost and accessibility.

The Opportunity

$310 Billion

The global mHealth apps market size is expected to reach USD $310 billion by 2027. Benefits that improve lifestyle and treatment outcomes is one of the key factors driving the growth of this market. Ref.

Why Nurosene?

Nurosene is committed to providing tools and technology that empower individuals to take control of and enhance their mental wellness. Our mission is to build the next generation of better, healthier brains.

Corporate Directory

Nurosene

[Head Office]

1655 Dupont St. #Suite 101

Toronto, ON M6P 3S9

investors@nurosene.com

DLA Piper

[Legal]

6000-150 King St. W

Toronto, ON M5X 1E2

416.365.3500

MNP LLP

[Auditors]

111 Richmond St. W Suite 300

Toronto, ON M5H 2G4

416.596.1711

Odyssey Trust

[Transfer Agent]

United Kingdom Building 323

409 Granville Street

Vancouver, BC V6C 1T2

1.833.392.7716